Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Custom Research Competitive Landscape Industry News FAQ
On This Report

Arterial Cannula Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use, Size), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11716| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Arterial Cannula Market size was over USD 24.9 million in 2026 and is likely to grow at a 7.13% CAGR between 2027 and 2036, surpassing USD 49.58 million by 2036. The industry revenue for 2027 is estimated at USD 26.39 million.

Base Year Value (2026)
USD 24.9 million
CAGR (2027-2036)
7.13%
Forecast Year Value (2036)
USD 49.58 million
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Arterial Cannula Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 42.88% share in 2026, supported by high cardiovascular procedure volumes, advanced hospital infrastructure, and consistent arterial cannula use across major cardiac centers.
  • Asia Pacific is expected to grow at an 8.59% CAGR as expanding hospital capabilities and increasing cardiac procedure volumes strengthen demand across developing healthcare systems.

Segment Momentum

  • ECMO accounted for 44.52% of the market in 2026 due to its reliance on arterial cannulas for prolonged circulatory and respiratory support in high-acuity hospital settings.
  • Ambulatory Surgical Centers are the fastest-growing end-use segment as healthcare providers increasingly shift appropriate procedures to efficient outpatient facilities focused on streamlined surgical workflows and cost control.

Market Expansion Drivers

  • Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures.
  • Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas.
  • Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes.

Leading Market Participants

  • Leading companies in the arterial cannula market include Medtronic plc (Ireland), Getinge AB (Sweden), LivaNova PLC (United Kingdom), Edwards Lifesciences Corporation (United States), Becton, Dickinson and Company (United States), Fresenius Medical Care AG & Co. KGaA (Germany), Nipro Corporation (Japan), Andocor NV (Belgium), Kangxin Medical Technology Co., Ltd. (China), Surgical Holdings Limited (United Kingdom).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 24.9 million
  • 2027 Estimated Market Size: USD 26.39 million.
  • Projected Market Size: USD 49.58 million by 2036
  • Growth Forecast: 7.13% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Extracorporeal Membrane Oxygenation (ECMO) (Application) | Hospitals (End Use) | 20-22 Fr (Size)
  • Emerging Opportunity Segment: Cardiopulmonary Bypass Surgery (Application) | Ambulatory Surgical Centers (End Use) | 35-36 Fr (Size)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures

The increasing prevalence of cardiovascular diseases is supporting higher utilization of advanced interventions such as coronary artery bypass grafting and extracorporeal membrane oxygenation, thereby driving the arterial cannula market growth. As the burden of cardiovascular conditions increases, healthcare providers require reliable vascular access devices that can facilitate blood circulation during complex surgical and life-support procedures. Arterial cannulas are important components in these settings because they enable controlled blood flow and support the operation of extracorporeal circulation systems. Growing procedural requirements across cardiac surgery and critical care environments are consequently creating sustained demand for cannulation products suited to different clinical applications and patient requirements.

Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas

The growing preference for minimally invasive surgical techniques is creating opportunities for the arterial cannula market by increasing the need for devices that can provide effective vascular access while minimizing tissue trauma. Modern cardiovascular procedures increasingly emphasize smaller access points, improved procedural precision, and reduced recovery requirements, placing greater importance on cannula design, flexibility, and compatibility with the patient's anatomy. Advances in biocompatible materials can also help reduce adverse tissue responses and support safer use during procedures requiring vascular access. These characteristics are encouraging healthcare facilities and surgical teams to adopt more technologically advanced cannulation solutions for procedures where device performance and patient compatibility are critical.

Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes

An expanding elderly population and the increasing incidence of diabetes are contributing to a larger pool of patients requiring cardiovascular monitoring, intervention, and surgical treatment, which will boost arterial cannula market demand. Aging is associated with a greater likelihood of complex cardiovascular conditions, while diabetes can contribute to vascular complications and increase the need for specialized cardiovascular care. Patients with multiple risk factors may require more intensive clinical management and procedures involving extracorporeal circulation or other forms of vascular access. This evolving patient profile is increasing the workload across cardiac care settings and supporting continued utilization of arterial cannulation devices in hospitals and specialized treatment facilities.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures 2.10% High North America, Europe High Near Term
Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas 1.80% High North America, Asia Pacific High Mid Term
Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes 1.50% Moderate Asia Pacific, Europe Medium Long Term

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Arterial Cannula Market
Largest Region
North America
42.88% Market Share in 2026

North America (Largest Region)

Holding the largest share of the arterial cannula market at 42.88% in 2026, North America benefits from advanced hospital infrastructure, strong critical care capabilities, and widespread use of invasive hemodynamic monitoring in complex clinical settings. High demand for intensive care, cardiovascular procedures, and surgical interventions supports the use of arterial cannulas, while established clinical protocols and access to specialized medical devices reinforce adoption. Continued investment in hospital technologies and critical care services further strengthens regional demand.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is expected to register the fastest growth as healthcare infrastructure expands and access to advanced critical care services improves. Increasing hospital capacity, rising awareness of intensive monitoring techniques, and growing demand for cardiovascular and surgical care are supporting wider use of arterial cannulas. Improvements in clinical capabilities and healthcare investment across developing markets are also helping expand access to sophisticated monitoring and intervention procedures.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
🔒 Need data on a specific country or region?. Individual country/region reports are available at discounted pricing. Inquire Before Buying
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Surgical Devices

Germany focuses on arterial cannulas that support high standards in cardiovascular surgery and perfusion procedures. Hospitals in Germany emphasize product quality, reliable clinical performance, and compatibility with sophisticated operating room technologies.

France 🇫🇷

Surgical Care Standardization

France prioritizes arterial cannulas that align with standardized cardiovascular treatment protocols and hospital quality requirements. Clinical teams in France emphasize dependable product performance and ease of use during complex cardiac procedures.

Italy 🇮🇹

Cardiovascular Treatment Efficiency

Italy supports arterial cannula adoption across hospitals performing cardiovascular and critical care procedures. Healthcare providers in Italy focus on products that improve procedural reliability while meeting established clinical practice requirements.

Japan 🇯🇵

Minimally Invasive Compatibility

Japan promotes arterial cannulas designed for precise cardiovascular interventions and evolving surgical techniques. Medical institutions in Japan value dependable device performance that supports procedural accuracy and improved patient management during complex surgeries.

South Korea 🇰🇷

Advanced Perfusion Solutions

South Korea expands the use of arterial cannulas through continued investment in specialized cardiac care facilities. Healthcare providers in South Korea seek devices that integrate efficiently with modern perfusion equipment while supporting consistent clinical outcomes.

United States 🇺🇸

Cardiac Procedure Support

The U.S. maintains consistent demand for arterial cannulas driven by cardiac surgery, extracorporeal circulation, and critical care applications. Healthcare providers in the U.S. prioritize products that enhance procedural efficiency, patient safety, and compatibility with advanced perfusion systems.

Segment Analysis

Segment Leadership and Growth Trends

Arterial Cannula Market Share (%), by Application, 2026

Extracorporeal Membrane Oxygenation (ECMO)
Cardiopulmonary Bypass Surgery
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Application Segment Analysis: Extracorporeal Membrane Oxygenation (ECMO) (Largest Segment) vs Cardiopulmonary Bypass Surgery (Fastest-Growing Segment)

Extracorporeal membrane oxygenation (ECMO) represented the largest share of the arterial cannula market, accounting for 44.52% in 2026, supported by the critical role of arterial cannulation in providing circulatory support for patients requiring advanced life-support interventions. ECMO procedures depend on reliable vascular access and carefully designed cannula systems to facilitate blood flow between the patient and extracorporeal support equipment. Increasing utilization of advanced critical-care technologies and greater focus on managing severe cardiopulmonary conditions are supporting demand for specialized cannulation solutions. The need for dependable performance, appropriate blood-flow management, and procedural safety further reinforces the importance of arterial cannulas in ECMO applications.

Cardiopulmonary bypass surgery is anticipated to be the fastest-growing application segment, driven by continued demand for surgical procedures requiring temporary extracorporeal circulation and dependable vascular access. Arterial cannulas are integral to cardiopulmonary bypass procedures because they provide the pathway necessary for circulating oxygenated blood during cardiac surgery. Improvements in surgical techniques and increasing emphasis on procedural efficiency and patient safety are encouraging the use of reliable cannulation systems. As cardiac surgery continues to adopt more sophisticated approaches and healthcare providers prioritize consistent surgical performance, demand for arterial cannulas in cardiopulmonary bypass applications is expected to expand.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held the largest share of the arterial cannula market, accounting for 58.28% in 2026, owing to their concentration of complex cardiovascular procedures, critical-care services, and specialized surgical infrastructure. Hospitals typically maintain advanced operating rooms, intensive care units, extracorporeal support capabilities, and multidisciplinary teams required for procedures involving arterial cannulation. The growing need to manage complex cardiovascular and critical-care cases reinforces demand for dependable cannula systems within hospital settings. In addition, hospitals' ability to support advanced surgical interventions and provide comprehensive perioperative care makes them the primary end-use environment for arterial cannulas.

Ambulatory surgical centers are expected to register the fastest growth, supported by the broader shift toward efficient outpatient and short-stay surgical models where clinically appropriate. Advances in surgical techniques, anesthesia, monitoring, and perioperative management are enabling a wider range of procedures to be performed outside traditional inpatient environments. As healthcare providers seek to improve resource utilization, reduce unnecessary hospital stays, and expand access to specialized procedures, ambulatory surgical centers are gaining importance. This evolving care model is creating opportunities for compact, reliable, and procedure-specific medical devices, supporting increasing demand for arterial cannulation solutions in these settings.

Segment Sub-Segment Largest Segment Fastest Growing
Application Cardiopulmonary Bypass Surgery, Extracorporeal Membrane Oxygenation (ECMO), Others Extracorporeal Membrane Oxygenation (ECMO) Cardiopulmonary Bypass Surgery
End Use Hospitals, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Size 14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29- 31 Fr, 32-34 Fr, 35-36 Fr 20-22 Fr 35-36 Fr
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the arterial cannula market:

1. Medtronic plc (Ireland)

2. Getinge AB (Sweden)

3. LivaNova PLC (United Kingdom)

4. Edwards Lifesciences Corporation (United States)

5. Becton Dickinson and Company (United States)

6. Fresenius Medical Care AG & Co. KGaA (Germany)

7. Nipro Corporation (Japan)

8. Andocor NV (Belgium)

9. Kangxin Medical Technology Co. Ltd. (China)

10. Surgical Holdings Limited (United Kingdom)

The arterial cannula market is witnessing ongoing innovation focused on improving procedural safety, flow performance, and patient outcomes in cardiovascular procedures. Manufacturers are enhancing product designs and expanding manufacturing capabilities to meet rising demand for advanced minimally invasive surgical solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Medtronic plc (Ireland)
Getinge AB (Sweden)
LivaNova PLC (United Kingdom)
Edwards Lifesciences Corporation (United States)
Becton Dickinson and Company (United States)
Fresenius Medical Care AG & Co. KGaA (Germany)
Nipro Corporation (Japan)
Andocor NV (Belgium)
Kangxin Medical Technology Co. Ltd. (China)
Surgical Holdings Limited (United Kingdom).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Shockwave Medical Sep-24 Shockwave Medical expanded its peripheral intravascular lithotripsy (IVL) portfolio with the U.S. launch of the Shockwave E8 catheter. Designed for treating calcified arterial lesions, this innovation provides enhanced reach and efficiency in vascular procedures. By addressing complex calcified disease, the device strengthens the company’s competitive position in the arterial intervention space and supports clinical outcomes in patients with peripheral artery disease.
Arrow International Apr-24 The FDA initiated a Class I recall of Arrow International’s QuickFlash Radial Artery Catheterization Kits due to device malfunctions involving increased resistance. This significant quality-related action impacted over 330,000 units, highlighting critical supply chain and manufacturing safety standards. The recall underscores the potential for procedural risks in arterial access and necessitates rigorous quality control measures for manufacturers within the arterial cannula market.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Arterial Cannula Market — Custom Segments

Segment Sub-Segment
Cannula Design Straight Tip Cannulas, Angled Tip Cannulas, Curved Tip Cannulas, Dispersion Cannulas
Cannulation Site Aortic Cannulation, Femoral Cannulation, Axillary/Subclavian Cannulation, Other Peripheral Cannulation
Patient Population Adult Patients, Pediatric Patients, Neonatal Patients

Arterial Cannula Market — Custom TOC

Custom Chapter Chapter Details
Cardiovascular Procedure Trend Impact Analysis
  • Cardiovascular Procedure Evolution and Demand Shifts
  • Procedure Complexity and Cannulation Requirement Trends
  • Technology Adoption Across Cardiovascular Interventions
  • Emerging Procedure Pathways and Market Opportunity Implications
Hospital Procurement and Tender Strategy Analysis
  • Hospital Purchasing Models and Procurement Decision Frameworks
  • Tender Evaluation Criteria and Supplier Selection Priorities
  • Contracting, Reimbursement, and Cost-Containment Considerations
  • Procurement Trends Across Public and Private Healthcare Systems
  • Strategic Implications for Supplier Engagement
Cannula Design Innovation Opportunity Assessment
  • Unmet Clinical Needs and Cannulation Performance Priorities
  • Material, Coating, and Design Innovation Trends
  • Product Differentiation and Feature Prioritization
  • Innovation Opportunities Across Procedure-Specific Applications

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current revenue of the arterial cannula market?

The market revenue for arterial cannula is anticipated at USD 26.39 million in 2027.

How much is the arterial cannula industry expected to grow by 2036?

Arterial Cannula Market size was over USD 24.9 million in 2026 and is likely to grow at a 7.13% CAGR between 2027 and 2036, surpassing USD 49.58 million by 2036.

How are rising CABG and ECMO procedure volumes impacting demand in the arterial cannula market?

Rising volumes of CABG and ECMO procedures are increasing arterial cannula consumption in cardiac surgery and intensive care settings, as clinicians prioritize stable flow performance, rapid setup, and reduced vascular trauma in high-risk cardiovascular interventions.

How are minimally invasive procedures and demographic shifts influencing arterial cannula adoption trends?

Minimally invasive cardiac procedures and rising elderly and diabetic populations are driving demand for advanced biocompatible arterial cannulas designed for smaller access points, improved maneuverability, and reduced complication risks in long-duration vascular support cases.

Why is Extracorporeal Membrane Oxygenation (ECMO) the largest application in the arterial cannula market?

ECMO accounted for 44.52% of the market in 2026 due to its reliance on arterial cannulas for prolonged circulatory and respiratory support in high-acuity hospital settings.

Which end-use segment is expanding fastest in the arterial cannula market?

Ambulatory Surgical Centers are the fastest-growing end-use segment as healthcare providers increasingly shift appropriate procedures to efficient outpatient facilities focused on streamlined surgical workflows and cost control.

Why does North America dominate the arterial cannula market?

North America held a 42.88% share in 2026, supported by high cardiovascular procedure volumes, advanced hospital infrastructure, and consistent arterial cannula use across major cardiac centers.

Why is Asia Pacific experiencing rapid growth in the arterial cannula market?

Asia Pacific is expected to grow at an 8.59% CAGR as expanding hospital capabilities and increasing cardiac procedure volumes strengthen demand across developing healthcare systems.

Which companies are driving growth in the arterial cannula landscape?

Leading companies in the arterial cannula market include Medtronic plc (Ireland), Getinge AB (Sweden), LivaNova PLC (United Kingdom), Edwards Lifesciences Corporation (United States), Becton, Dickinson and Company (United States), Fresenius Medical Care AG & Co. KGaA (Germany), Nipro Corporation (Japan), Andocor NV (Belgium), Kangxin Medical Technology Co., Ltd. (China), Surgical Holdings Limited (United Kingdom).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Read our Research Approach →

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →